Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease
Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi
Molecular Neurobiology (2021) Vol. 58, Iss. 8, pp. 4178-4187
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

COVID-19 and the role of cytokines in this disease
Amin Hasanvand
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 789-798
Open Access | Times Cited: 92
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharis C. Theoharides, Duraisamy Kempuraj
Cells (2023) Vol. 12, Iss. 5, pp. 688-688
Open Access | Times Cited: 52
A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins
Danielle G. May, Laura Martin‐Sancho, Valesca Anschau, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 611-611
Open Access | Times Cited: 41
Ancestral allele of DNA polymerase gamma modifies antiviral tolerance
Yilin Kang, Jussi Hepojoki, Rocío Maldonado, et al.
Nature (2024) Vol. 628, Iss. 8009, pp. 844-853
Open Access | Times Cited: 7
Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality
Dun‐Xian Tan, Rüssel J. Reiter
Life Sciences (2022) Vol. 294, pp. 120368-120368
Open Access | Times Cited: 29
Long-Term Sequelae of COVID-19 in Experimental Mice
Michael J. Paidas, Daniela S. Cosio, Saad Ali, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 5970-5986
Open Access | Times Cited: 28
Recombinant SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Stimulate Release of Different Pro-Inflammatory Mediators via Activation of Distinct Receptors on Human Microglia Cells
Irene Tsilioni, Theoharis C. Theoharides
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6704-6714
Closed Access | Times Cited: 15
A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review)
Ioannis Lempesis, Vasiliki Georgakopoulou, Rüssel J. Reiter, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 3
Open Access | Times Cited: 5
Involvement of virus infections and antiviral agents in schizophrenia
Alejandro Borrego-Ruiz, Juan J. Borrego
Psychological Medicine (2025) Vol. 55
Closed Access
On fine particulate matter and COVID-19 spread and severity: An in vitro toxicological plausible mechanism
Sara Marchetti, Maurizio Gualtieri, Andrea Pozzer, et al.
Environment International (2023) Vol. 179, pp. 108131-108131
Open Access | Times Cited: 10
Application of methylene blue for the prevention and treatment of COVID-19: A narrative review.
Elaheh Emadi, Daryoush Hamidi Alamdari, Davood Attaran, et al.
PubMed (2024) Vol. 27, Iss. 7, pp. 780-792
Closed Access | Times Cited: 3
Acute and long-term effects of COVID-19 on brain and mental health: A narrative review
J. Douglas Bremner, Scott J. Russo, Richard J. Gallagher, et al.
Brain Behavior and Immunity (2024) Vol. 123, pp. 928-945
Closed Access | Times Cited: 3
Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series
Anna Gil, George E. Hoag, John P. Salerno, et al.
Brain Behavior & Immunity - Health (2023) Vol. 36, pp. 100720-100720
Open Access | Times Cited: 9
The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19
Sonia Emanuele, Adriana Celesia, Antonella D’Anneo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7963-7963
Open Access | Times Cited: 21
Exploring nanoselenium to tackle mutated SARS-CoV-2 for efficient COVID-19 management
Avtar Singh, Paramjit Singh, Rajeev Kumar, et al.
Frontiers in Nanotechnology (2022) Vol. 4
Open Access | Times Cited: 13
Role of Tau protein in long COVID and potential therapeutic targets
Bharat Marwaha
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
Identifying novel inhibitors targeting Exportin-1 for the potential treatment of COVID-19
Tanuj Sharma, Tanmoy Mondal, Sajid Khan, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 2
Closed Access | Times Cited: 1
Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination
Saishravan Shyamsundar, Sheila K. Pierson, Caoilfhionn M Connolly, et al.
Deleted Journal (2024) Vol. 1, Iss. 1, pp. 100002-100002
Open Access | Times Cited: 1
Post-Covid Syndrome: from Biology to Neuropsychology
Anna Е. Karchevskaya, Y. O. Vologdina, О. С. Зайцев, et al.
Moscow University Psychology Bulletin (2024) Vol. 47, Iss. 1, pp. 31-55
Open Access | Times Cited: 1
Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, et al.
Drug repurposing (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
COVID‐19 and the increase in schizophrenia incidence in the future: A hypothesis and a serious warning
Mohammad Pourfridoni, Hedyeh Askarpour
Health Science Reports (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 8
Nano-engineered vitamins as a potential epigenetic modifier against environmental air pollutants
Pooja Ratre, Prachi Chauhan, Arpit Bhargava, et al.
Reviews on Environmental Health (2022) Vol. 38, Iss. 3, pp. 547-564
Closed Access | Times Cited: 6
Correlations between Cytokine Levels, Liver Function Markers, and Neuropilin-1 Expression in Patients with COVID-19
Salma A. El Kazafy, Yasser Fouad, Azza Farag Said, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1636-1636
Open Access | Times Cited: 6
From Innate Immunity to Inflammation: A Primer on Multiple Facets of NF-κB Signaling in COVID-19
Ashutosh Pandey, Abhinava K. Mishra
Physiologia (2022) Vol. 2, Iss. 2, pp. 34-45
Open Access | Times Cited: 5
Recombinant SARS-CoV-2 Spike Protein and its Receptor Binding Domain stimulate release of different pro-inflammatory mediators via activation of distinct receptors on human microglia cells
Irene Tsilioni, Theoharis C. Theoharides
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top